Prescription drug prices
What they say
His campaign says that in the legislature he fought hard to successfully lower prescription drug prices.
“Troy fought hard to successfully lower prescription drug prices”
What the record shows ·
In 2019, as Senate President, he sponsored two prescription-drug bills that became law: LD 1499, which created the Maine Prescription Drug Affordability Board, and LD 1272, An Act To Increase Access to Low-cost Prescription Drugs. The Senate accepted the committee's majority report on each 35 to 0 on June 11, 2019, with his Yea vote (Roll Calls 264 and 263), and later enacted both without a recorded vote; the House enacted them 126 to 15 and 138 to 3. Both were signed on June 24, 2019, as Public Law 2019, chapters 471 and 472. In 2021 he sponsored LD 1117, An Act To Prevent Excessive Prices for Prescription Drugs. Both chambers passed it, the Governor vetoed it, and the Senate's override vote, 20 to 14 with his Yea, fell short of the 23 votes needed (Roll Call 506). In 2024 his LD 2114 became a resolve, Resolve 2024, chapter 177, directing the Superintendent of Insurance to collect data on how insurers cover generic drugs and biosimilars and to report to the Legislature.
Why there is no assessment here
The claim is that prices came down, and no official source read for this desk publishes that figure. The laws set up a board and a program; the record shows them enacted, not what they changed at the pharmacy counter. The next test is the Prescription Drug Affordability Board's annual reports to the Legislature.
Limit: Sponsorship, his votes and enactment are on the record; the outcome the sentence claims is not.